Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.
about
Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β.What is a preferred angiotensin II receptor blocker-based combination therapy for blood pressure control in hypertensive patients with diabetic and non-diabetic renal impairment?Increased Transforming Growth Factor-β Levels Associated With Cardiac Adverse Events in Hypertrophic Cardiomyopathy.
P2860
Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical experience in treatin ...... rtan plus hydrochlorothiazide.
@en
Clinical experience in treatin ...... rtan plus hydrochlorothiazide.
@nl
type
label
Clinical experience in treatin ...... rtan plus hydrochlorothiazide.
@en
Clinical experience in treatin ...... rtan plus hydrochlorothiazide.
@nl
prefLabel
Clinical experience in treatin ...... rtan plus hydrochlorothiazide.
@en
Clinical experience in treatin ...... rtan plus hydrochlorothiazide.
@nl
P2093
P2860
P1476
Clinical experience in treatin ...... rtan plus hydrochlorothiazide.
@en
P2093
Kazuyoshi Okada
Koichi Matsumoto
Masanori Abe
P2860
P304
P356
10.1517/17425250903282799
P407
P577
2009-10-01T00:00:00Z